Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 15

3.

Ezetimibe: rescued by randomization (clinical and mendelian).

McPherson R, Hegele RA.

Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):e13-5. doi: 10.1161/ATVBAHA.114.305012. Epub 2014 Dec 30. No abstract available.

4.

Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).

Kruger R, Rasmussen LM, Argraves WS, Eugen-Olsen J, Nielsen OW, Blyme A, Willenheimer R, Wachtell K, Olsen MH.

PLoS One. 2014 Jul 11;9(7):e101522. doi: 10.1371/journal.pone.0101522. eCollection 2014.

5.

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study.

Ballantyne CM, Hoogeveen RC, Raya JL, Cain VA, Palmer MK, Karlson BW; GRAVITY Study Investigators.

Atherosclerosis. 2014 Jan;232(1):86-93. doi: 10.1016/j.atherosclerosis.2013.10.022. Epub 2013 Nov 1.

PMID:
24401221
6.

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.

Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K.

Vasc Health Risk Manag. 2013;9:719-27. doi: 10.2147/VHRM.S49840. Epub 2013 Nov 15.

7.

Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients.

Le NA, Jin R, Tomassini JE, Tershakovec AM, Neff DR, Wilson PW.

J Am Heart Assoc. 2013 Aug 7;2(4):e000037. doi: 10.1161/JAHA.113.000037.

8.

Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K.

Int J Cardiol. 2013 Jun 5;166(1):72-6. doi: 10.1016/j.ijcard.2011.09.064. Epub 2011 Oct 11.

PMID:
21996417
9.

Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.

Averna M, Missault L, Vaverkova H, Farnier M, Viigimaa M, Dong Q, Shah A, Johnson-Levonas AO, Taggart W, Brudi P.

Diab Vasc Dis Res. 2011 Oct;8(4):262-70. doi: 10.1177/1479164111418136. Epub 2011 Aug 22.

PMID:
21859750
10.

Pleiotropic effects of ezetimibe/simvastatin vs. high dose simvastatin.

Pesaro AE, Serrano CV Jr, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, Maranhão RC, de Lemos JA, Souza HP, Nicolau JC.

Int J Cardiol. 2012 Jul 26;158(3):400-4. doi: 10.1016/j.ijcard.2011.01.062. Epub 2011 Feb 21.

11.

Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.

Ahmed MH, Khalil AA.

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1021-9. Review.

12.

Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).

Foody JM, Brown WV, Zieve F, Adewale AJ, Flaim D, Lowe RS, Jones-Burton C, Tershakovec AM.

Am J Cardiol. 2010 Nov 1;106(9):1255-63. doi: 10.1016/j.amjcard.2010.06.051.

PMID:
21029821
13.

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study).

Bardini G, Giorda CB, Pontiroli AE, Le Grazie C, Rotella CM.

Cardiovasc Diabetol. 2010 May 21;9:20. doi: 10.1186/1475-2840-9-20.

14.

Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).

Tuseth N, Cramariuc D, Rieck AE, Wachtell K, Gerdts E.

Blood Press. 2010 Jun;19(3):140-4. doi: 10.3109/08037051.2010.481816.

PMID:
20429691
15.

Carotid intima-media thickness (cIMT): a useful clinic tool or research luxury? Another view of the ENHANCE trial.

Toutouzas P, Richter D.

Angiology. 2008 Apr-May;59(2 Suppl):77S-9S. doi: 10.1177/0003319708321748. Epub 2008 Jul 15. Review.

PMID:
18628278
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk